| Abstract: | Datamonitor's Respironics, Inc. - SWOT Analysis company profile is the essential source for top-level company data and information. Respironics, Inc. - SWOT Analysis examines the company's key business structure and operations, history and products, and provides summary analysis of its key revenue lines and strategy.
Respironics provides solutions for the global sleep and respiratory markets. It manufactures and markets medical devices for the treatment of patients suffering from respiratory disorders. The company primarily operates in the US. It is headquartered in Murrysville, Pennsylvania, and employs about 4,900 people. The company recorded revenues of $1,195 million during the fiscal year ended June 2007, an increase of 14.2% over 2006. The operating profit of the company was $174.8 million during fiscal year 2007, an increase of 9.8% over 2006. The net profit was $122.3 million in fiscal year 2007, an increase of 22.4% over 2006.
Scope of the Report
- Provides all the crucial information on Respironics, Inc. required for business and competitor intelligence needs
- Contains a study of the major internal and external factors affecting Respironics, Inc. in the form of a SWOT analysis as well as a breakdown and examination of leading product revenue streams of Respironics, Inc.
-Data is supplemented with details on Respironics, Inc. history, key executives, business description, locations and subsidiaries as well as a list of products and services and the latest available statement from Respironics, Inc.
Reasons to Purchase
- Support sales activities by understanding your customers' businesses better
- Qualify prospective partners and suppliers
- Keep fully up to date on your competitors' business structure, strategy and prospects
- Obtain the most up to date company information available
|
| Brief Excerpt: | ...Respironics pro vides solutions f or the global sleep and respir atory mar kets. It man ufactures and markets medical de vices f or the treatment of patients suff ering from respir atory disorders .Thecompany pr imarily oper ates in the US . It is headquar tered in Murr ysville, P ennsylvania, and emplo ysabout 4,900 people .The compan y recorded re venues of $1,195 million dur ing the fiscal y ear ended J une 2007, an increase of 14.2% o ver 2006. The oper ating profit of the compan y w as $174.8 million dur ing fiscal year 2007, an increase of 9.8% o ver 2006. The net profit w as $122.3 million in fiscal y ear 2007, an increase of 22.4% o ver 2006. ...
|
